These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2877564

  • 1. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
    Rodrigues EA, Lahiri A, Hughes LO, Kohli RS, Whittington JR, Raftery EB.
    Am J Cardiol; 1986 Nov 01; 58(10):916-21. PubMed ID: 2877564
    [Abstract] [Full Text] [Related]

  • 2. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
    Lahiri A, Rodrigues EA, Al-Khawaja I, Raftery EB.
    Am J Cardiol; 1987 Apr 01; 59(8):769-74. PubMed ID: 2881480
    [Abstract] [Full Text] [Related]

  • 3. Comparison of carvedilol and atenolol for angina pectoris.
    Freedman SB, Jamal SM, Harris PJ, Kelly DT.
    Am J Cardiol; 1987 Sep 01; 60(7):499-502. PubMed ID: 2888302
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.
    Kaski JC, Rodriguez-Plaza L, Brown J, Maseri A.
    Am J Cardiol; 1985 Jul 01; 56(1):35-40. PubMed ID: 2861738
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
    Kishida H, Saito T, Fukuma N, Hata N, Suzuki T, Ohtsu F.
    Jpn Heart J; 1990 Jul 01; 31(4):449-60. PubMed ID: 1977939
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ, Khurmi NS, O'Hara MJ, Raftery EB.
    Am J Cardiol; 1986 Nov 26; 58(12):28E-34E. PubMed ID: 2878598
    [Abstract] [Full Text] [Related]

  • 7. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM, Freedman SB, Thomson A, Carter G, Harris PJ, Kelly DT.
    J Cardiovasc Pharmacol; 1987 Nov 26; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [Abstract] [Full Text] [Related]

  • 8. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ, Low RI, Paumer L, Amsterdam EA, Mason DT.
    Am J Cardiol; 1983 Jan 01; 51(1):13-8. PubMed ID: 6129794
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of carvedilol in exercise-induced myocardial ischemia.
    Kaski JC, Rodriguez-Plaza L, Brown J, Maseri A.
    J Cardiovasc Pharmacol; 1987 Jan 01; 10 Suppl 11():S137-40. PubMed ID: 2454360
    [Abstract] [Full Text] [Related]

  • 10. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
    van der Does R, Hauf-Zachariou U, Pfarr E, Holtbrügge W, König S, Griffiths M, Lahiri A.
    Am J Cardiol; 1999 Mar 01; 83(5):643-9. PubMed ID: 10080412
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of carvedilol in unstable angina pectoris.
    Brunner M, Faber TS, Greve B, Keck A, Schnabel P, Jeron A, Meinertz T, Just H, Zehender M.
    Am J Cardiol; 2000 May 15; 85(10):1173-8. PubMed ID: 10801996
    [Abstract] [Full Text] [Related]

  • 12. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
    Lahiri A, Rodrigues EA, DasGupta P, Jain D, van der Does R, Raftery EB.
    Z Kardiol; 1989 May 15; 78 Suppl 3():21-7. PubMed ID: 2573213
    [Abstract] [Full Text] [Related]

  • 13. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
    Hauf-Zachariou U, Blackwood RA, Gunawardena KA, O'Donnell JG, Garnham S, Pfarr E.
    Eur J Clin Pharmacol; 1997 May 15; 52(2):95-100. PubMed ID: 9174677
    [Abstract] [Full Text] [Related]

  • 14. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.
    Nahrendorf W, Rading A, Steinig G, van der Does R, Schlote A.
    J Cardiovasc Pharmacol; 1992 May 15; 19 Suppl 1():S114-6. PubMed ID: 1378136
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP, Durier P, Bussiere JL, Gayet JL.
    Eur J Clin Pharmacol; 1990 May 15; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [Abstract] [Full Text] [Related]

  • 16. Carvedilol for systemic hypertension.
    Heber ME, Brigden GS, Caruana MP, Lahiri A, Raftery EB.
    Am J Cardiol; 1987 Feb 15; 59(5):400-5. PubMed ID: 2880498
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
    Martsevich SIu, Koniakhina IP, Alimova EV, Kutishenko NP, Lerman OV.
    Ter Arkh; 2001 Feb 15; 73(1):38-41. PubMed ID: 11234138
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
    Kohli RS, Lahiri A, Raftery EB.
    J Cardiovasc Pharmacol; 1986 Feb 15; 8 Suppl 11():S148-53. PubMed ID: 2439787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.